Depression is associated with an altered immune response, which could be normalized by antidepressant drugs. However, little is known about the influence of antidepressants on the peripheral immune response and function of macrophages in individuals not suffering from depression. Our studies were aimed at determining the influence of antidepressant drugs on the humoral and cellular immune response in mice. Mice were treated intraperitoneally with imipramine, fluoxetine, venlafaxine, or moclobemide and contact immunized with trinitrophenyl hapten followed by elicitation and measurement of contact sensitivity by ear swelling response. Peritoneal macrophages from drug-treated mice were either pulsed with sheep erythrocytes or conjugated with trinitrophenyl and transferred into naive recipients to induce humoral or contact sensitivity response, respectively. Secretion of reactive oxygen intermediates, nitric oxide, and cytokines by macrophages from drug-treated mice was assessed, respectively, in chemiluminometry, Griess-based colorimetry and enzyme-linked immunosorbent assay, and the expression of macrophage surface markers was analyzed cytometrically. Treatment of mice with fluoxetine, venlafaxine, and moclobemide results in suppression of humoral and cell-mediated immunity with a reduction of the release of macrophage proinflammatory mediators and the expression of antigen-presentation markers. In contrast, treatment with imipramine enhanced the humoral immune response and macrophage secretory activity but slightly suppressed active contact sensitivity. Our studies demonstrated that systemically delivered antidepressant drugs modulate the peripheral humoral and cell-mediated immune responses, mostly through their action on macrophages. Imipramine was rather proinflammatory, whereas other tested drugs expressed immunosuppressive potential. Current observations may be applied to new therapeutic strategies dedicated to various disorders associated with excessive inflammation.
HickieILloydA. Are cytokines associated with neuropsychiatric syndromes in humans?Int J Immunopharmacol1995; 17: 677–83.
2.
SmithRS. The macrophage theory of depression. Med Hypotheses1991; 35: 298–306.
3.
BeumerWGibneySMDrexhageRCPont-LezicaLDoorduinJKleinHCSteinerJConnorTJHarkinAVersnelMADrexhageHA. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol2012; 92: 959–75.
4.
KulmatyckiKMJamaliF. Drug disease interactions: role of inflammatory mediators in depression and variability in antidepressant drug response. J Pharm Pharm Sci2006; 9: 292–306.
5.
MillerAHMaleticVRaisonCL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry2009; 65: 732–41.
6.
RaisonCLRutherfordREWoolwineBJShuoCSchettlerPDrakeDFHaroonEMillerAH. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry2013; 70: 31–41.
7.
CapuronLMillerAH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther2011; 130: 226–38.
8.
MoonMLMcNeilLKFreundGG. Macrophages make me sick: how macrophage activation states influence sickness behavior. Psychoneuroendocrinology2011; 36: 1431–40.
9.
LeonardBE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev2010; 6: 205–12.
10.
HaroonERaisonCLMillerAH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology2012; 37: 137–62.
11.
DinanTG. Inflammatory markers in depression. Curr Opin Psychiatry2009; 22: 32–6.
12.
ReicheEMNunesSOMorimotoHK. Stress, depression, the immune system, and cancer. Lancet Oncol2004; 5: 617–25.
13.
NazimekKBryniarskiK. The biological activity of macrophages in health and disease. Postepy Hig Med Dosw2012; 66: 507–20.
14.
NazimekKFilipczak-BryniarskaIBryniarskiK. The role of medicaments, exosomes and miRNA molecules in modulation of macrophage immune activity. Postepy Hig Med Dosw2015; 69: 1114–29.
15.
PrinzMPrillerJSisodiaSSRansohoffRM. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci2011; 14: 1227–35.
16.
RomanAKreinerGNalepaI. Macrophages and depression – a misalliance or well-arranged marriage?Pharmacol Rep2013; 65: 1663–72.
17.
HaenischBBönischH. Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters. Pharmacol Ther2011; 129: 352–68.
18.
ShajibMSKhanWI. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf)2015; 213: 561–74.
19.
SlotaCShiAChenGBevansMWengNP. Norepinephrine preferentially modulates memory CD8 T cell function inducing inflammatory cytokine production and reducing proliferation in response to activation. Brain Behav Immun2015; 46: 168–79.
20.
LeeKMKimYK. The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder. Int Immunopharmacol2006; 6: 1298–304.
21.
HannestadJDellagioiaNBlochM. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology2011; 36: 2452–9.
22.
CzajkowskaBPtakMBobekMBryniarskiKSzczepanikM. Different isoenzyme patterns of nonspecific esterases and the level of IL-6 production as markers of macrophage functions. Folia Histochem Cytobiol1995; 33: 111–5.
23.
MarzinzigMNusslerAKStadlerJMarzinzigEBarthlenWNusslerNCBegerHGMorrisSMJrBrucknerUB. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide1997; 1: 177–89.
24.
Filipczak-BryniarskaINowakBSikoraENazimekKWoronJWordliczekJBryniarskiK. The influence of opioids on the humoral and cell-mediated immune responses in mice. The role of macrophages. Pharmacol Rep2012; 64: 1200–15.
25.
PtakWBeretaMPtakMIversonGMGreenDR. Suppression and contrasuppression in the induction of contact sensitivity by the administration of cell bound antigen-antibody complexes. J Immunol1985; 135: 2312–8.
26.
JanssenDGCaniatoRNVersterJCBauneBT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol2010; 25: 201–15.
27.
KenisGMaesM. Effects of antidepressants on production of cytokines. Int J Neuropharmacol2002; 5: 401–12.
28.
HendersonDCEdwardsRGWestonBJDewdneyJM. Immunological studies on paroxetine, a novel anti-depressant drug. Int J Immunopharmacol1988; 10: 361–7.
29.
KuberaMCurzytekKMajewska-SzczepanikMSzczepanikMMarcinskaKPtakWLeskiewiczMMaesMBasta-KaimABudziszewskaBDetkaJDudaWLasonW. Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction. Pharmacol Rep2012; 64: 714–22.
30.
CurzytekKKuberaMMajewska-SzczepanikMSzczepanikMMarcinskaKPtakWDudaWLeskiewiczMBasta-KaimABudziszewskaBLasonWMaesM. Inhibition of 2,4-dinitrofluorobenzene-induced contact hypersensitivity reaction by antidepressant drugs. Pharmacol Rep2013; 65: 1237–46.
31.
KuberaMLinAHKenisGBosmansEvan BockstaeleDMaesM. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol2001; 21: 199–206.
32.
LinASongCKenisGBosmansEDe JonghRScharpeSMaesM. The in vitro immunosuppressive effects of moclobemide in healthy volunteers. J Affect Disord2000; 58: 69–74.
33.
MaesM. The immunomodulatory effects of antidepressants. Hum Psychopharmacol2001; 16: 95–103.
34.
KuberaMKenisGBosmansEKajtaMBasta-KaimAScharpeSBudziszewskaBMaesM. Stimulatory effect of antidepressants on the production of IL-6. Int Immunopharmacol2004; 4: 185–92.
35.
XiaZDePierreJWNassbergerL. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology1996; 34: 27–37.
36.
DurairajHSteuryMDParameswaranN. Paroxetine differentially modulates LPS-induced TNFa and IL-6 production in mouse macrophages. Int Immunopharmacol2015; 25: 485–92.
37.
RomanAKusmierczykJKlimekERogozZNalepaI. Effects of co-administration of fluoxetine and risperidone on properties of peritoneal and pleural macrophages in rats subjected to the forced swimming test. Pharmacol Rep2012; 64: 1368–80.
38.
HadjimitovaVTraykovTGoliyskiPRibarovS. Effects of some psychotropic drugs on the activated macrophage-induced luminol-dependent chemiluminescence. Pharmacol Toxicol1999; 84: 170–3.
39.
SuHCMaCTYuBCChienYCTsaiCCHuangWCLinCFChuangYHYoungKCWangJNTsaoCW. Glycogen synthase kinase-3β regulates anti-inflammatory property of fluoxetine. Int Immunopharmacol2012; 14: 150–6.
40.
El-NourHLundebergLAbdel-MagidNLonne-RahmSBAzmitiaECNordlindK. Serotonergic mechanisms in human allergic contact dermatitis. Acta Derm Venereol2007; 87: 390–6.
41.
CurzytekKKuberaMSzczepanikMBasta-KaimALeskiewiczMBudziszewskaBLasonWMaesM. Crosstalk between contact hypersensitivity reaction and antidepressant drugs. Pharmacol Rep2013; 65: 1673–80.
42.
CloonanSMWilliamsDC. The antidepressants maprotiline and fluoxetine induce type II autophagic cell death in drug-resistant Burkitt’s lymphoma. Int J Cancer2011; 128: 1712–23.
43.
DharmshaktuPTayalVKalraBS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol2012; 52: 6–17.
44.
MarchettiniPFormaglioFLancerenzaMNeuropathic pain. In: BrueraEHigginsonIvon GuntenCFMoritaT (eds). Textbook of palliative medicine and supportive care, Boca Raton: CRC Press and Taylor & Francis Group, 2015, pp. 481–92.
45.
HerrNMaulerMWitschTStallmannDSchmittSMezgerJBodeCDuerschmiedD. Acute fluoxetine treatment induces slow rolling of leukocytes on endothelium in mice. PLoS One2014; 9: e88316–e88316.
46.
CastanonNLeonardBENeveuPJYirmiyaR. Effects of antidepressants on cytokine production and actions. Brain Behav Immun2002; 16: 569–74.
47.
de Las Casas-EngelMCorbiAL. Serotonin modulation of macrophage polarization: inflammation and beyond. Adv Exp Med Biol2014; 824: 89–115.
48.
Branco-de-AlmeidaLSFrancoGCNCastroMLdos SantosJGAnbinderALCortelliSCKajiyaMKawaiTRosalenPL. Fluoxetine inhibits inflammatory response and bone loss in a rat model of ligature-induced periodontitis. J Periodontol2012; 83: 664–71.
49.
YaronIShiraziIJudovichRLevartovskyDCaspiDYaronM. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum1999; 42: 2561–8.
50.
KohSKimJMKimIKimNJungHCSongISKimJS. Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice. Am J Physiol Gastrointest Liver Physiol2011; 301: G9–19.
LeonardBE. The immune system, depression and the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry2001; 25: 767–80.
53.
KrishnadasRKrishnadasRCavanaghJ. Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature. J Med Case Rep2011; 5: 112–112.
54.
SacreSMedghalchiMGregoryBBrennanFWilliamsR. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum2010; 62: 683–93.
55.
IskandarHNCassellBKanuriNGyawaliCPGutierrezADassopoulosTCiorbaMASayukGS. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol2014; 48: 423–9.
56.
VollmarPNesslerSKalluriSRHartungHPHemmerB. The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. Int J Neuropsychopharmacol2009; 12: 525–36.
57.
YingGKarlssonHDePierreJWNassbergerL. Tricyclic antidepressants prevent the differentiation of monocytes into macrophage-like cells in vitro. Cell Biol Toxicol2002; 18: 425–37.
